CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)	12 Months Ended
	Dec. 31, 2016	Dec. 31, 2015	Dec. 31, 2014
Cash flows from operating activities:
Net loss	$ (76,700,000)	$ (304,400,000)	$ (24,200,000)
Reconciliations of net loss to net cash flows provided by operating activities:
Depreciation and amortization	342,300,000	251,000,000	88,000,000
Deferred income taxes	(57,400,000)	(45,500,000)	(43,200,000)
Manufacturer's profit in inventory adjustment	11,700,000	76,500,000	35,500,000
Unrealized foreign exchange loss	43,800,000	97,300,000	2,000,000
Non-cash fair value adjustment to contingent consideration	5,100,000	6,800,000	29,100,000
Goodwill impairment	46,600,000	0	0
Other, net	(22,900,000)	29,800,000	7,200,000
Changes in assets and liabilities, net of acquisitions:
Accounts receivable	(18,900,000)	66,700,000	4,900,000
Inventory	70,400,000	(7,300,000)	11,400,000
Accounts payable	(67,300,000)	83,200,000	10,900,000
Accrued expenses	25,400,000	51,500,000	(15,700,000)
Other assets and liabilities	(117,300,000)	15,300,000	(7,700,000)
Net cash flows provided by operating activities	184,800,000	320,900,000	98,200,000
Cash flows from investing activities:
Capital expenditures	(56,300,000)	(47,900,000)	(18,500,000)
Investment in registrations of products	(36,400,000)	(34,400,000)	0
Proceeds from sale of assets	20,600,000	25,800,000	600,000
Acquisition of business, net of cash acquired	1,300,000	(4,600,300,000)	(1,361,800,000)
Restricted cash	0	599,700,000	(600,000,000)
Note receivable	0	(125,000,000)	0
Settlement of foreign exchange contracts in connection with acquisition	0	(73,100,000)	0
Other, net	(3,900,000)	(1,300,000)	(3,000,000)
Net cash flows used in investing activities	(74,700,000)	(4,256,500,000)	(1,982,700,000)
Cash flows from financing activities:
Debt proceeds, net of discount and premium	3,300,900,000	3,921,800,000	678,800,000
Repayments of borrowings	(3,340,100,000)	(283,700,000)	(9,100,000)
Change in lines of credit, net	54,000,000	(12,400,000)	0
Proceeds from issuance of common stock, net	391,500,000	469,500,000	1,512,600,000
Payment of financing fees	(1,100,000)	(87,000,000)	(13,200,000)
Settlement of Series B Convertible Preferred Stock	(460,000,000)	0	0
Other, net	(47,400,000)	(7,000,000)	(200,000)
Net cash flows (used in) provided by financing activities	(102,200,000)	4,001,200,000	2,168,900,000
Effect of exchange rate changes on cash and cash equivalents	(17,500,000)	(30,700,000)	(10,100,000)
Net (decrease) increase in cash and cash equivalents	(9,600,000)	34,900,000	274,300,000
Cash and cash equivalents at beginning of period	432,200,000	397,300,000	123,000,000
Cash and cash equivalents at end of period	422,600,000	432,200,000	397,300,000
Supplemental disclosure information:
Cash paid for interest	360,100,000	147,600,000	36,300,000
Cash paid for income taxes	121,200,000	73,300,000	27,500,000
Non-cash investing activities:
Unpaid capital expenditures included in accounts payable and accrued expenses	$ 7,100,000	$ 4,700,000	$ 2,400,000